SCHEMBL13071857

SCHEMBL13071857

CC1(S(=O)(=O)NC(=O)[C@@]23C[C@H]2/C=C\CCCCC[C@H](Nc2cccc(C(F)(F)F)c2)C(=O)N2C[C@H](O)C[C@H]2C(=O)N3)CC1

nearest known ligand 0.43

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.41
▸ CTSB P07858 1/20 0.33
▸ ADRB3 P13945 1/20 0.32
▸ ADRA2B P18089 1/20 0.32
▸ ADRA2C P18825 1/20 0.32
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ EPHX2 P34913 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12792858 0.94 CYP3A4 (0.40) CYP3A4CTSBADRB3ADRA2BADRA2C
SCHEMBL13071503 0.93 CYP3A4 (0.42) CYP3A4CTSBADRB3ADRA2BADRA2C
SCHEMBL12792802 0.92 CYP3A4 (0.40) CYP3A4CTSBADRB3ADRA2BADRA2C
SCHEMBL13071855 0.91 CYP3A4 (0.39) CYP3A4CTSBADRB3ADRA2BADRA2C
SCHEMBL7873797 0.90 CYP3A4 (0.39) CYP3A4CTSBADRB3ADRA2BADRA2C
SCHEMBL12844263 0.90 CYP3A4 (0.39) CYP3A4CTSBADRB3ADRA2BADRA2C
SCHEMBL13071382 0.86 CYP3A4 (0.39) CYP3A4CTSBADRB3ADRA2BADRA2C
SCHEMBL8378985 0.86 CYP3A4 (0.43) CYP3A4CTSBADRB3ADRA2BADRA2C
SCHEMBL7876693 0.86 CYP3A4 (0.45) CYP3A4CTSBADRB3ADRA2BADRA2C
SCHEMBL7871967 0.86 CYP3A4 (0.45) CYP3A4CTSBADRB3ADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009142842-A9 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2010-11-25 — — WO disclosed
WO-2009142842-A2 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2009-11-26 — — WO disclosed
Send feedback